MedTrace Logo

A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

NCT02707315 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-03-14

No results posted yet for this study

Summary

This study is evaluating stereotactic radiosurgery (CyberKnife) plus chemotherapy for the treatment of potentially resectable adenocarcinoma of the pancreas

Conditions

  • Pancreas Cancer
  • Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • Pancreas Adenocarcinoma
  • Pancreatic Adenocarcinoma

Interventions

DRUG

Gemcitabine

RADIATION

Stereotactic Radiosurgery

Sponsors & Collaborators

  • The Cooper Health System

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02707315 on ClinicalTrials.gov